Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis

Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-proven rare case of minimal change nephrotic syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Shima, Hisato, Okamoto, Takuya, Tashiro, Manabu, Inoue, Tomoko, Masaki, Chiaki, Tada, Hiroaki, Takamatsu, Norimichi, Kawahara, Kazuhiko, Okada, Kazuyoshi, Doi, Toshio, Minakuchi, Jun, Kawashima, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380391/
https://www.ncbi.nlm.nih.gov/pubmed/32734188
http://dx.doi.org/10.1016/j.xkme.2019.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380391/
https://www.ncbi.nlm.nih.gov/pubmed/32734188
http://dx.doi.org/10.1016/j.xkme.2019.03.001

Ejemplares similares